DCB Academy has been hosted in a groundbreaking symposium at the premier European Congress on Drug-Eluting Balloon (DEB) Angioplasty in Rome, on January 30-31. This event will serve as a unique platform for the global interventional cardiology community to engage in an advanced and comprehensive exploration of drug-coated balloon technology for coronary interventions.
Featuring prominent thought leaders and key opinion leaders from around the world, the congress will showcase live case demonstrations, in-depth lectures, and dynamic discussions designed to elevate the scientific understanding and clinical application of DEB in the context of coronary artery disease. This congress represents an exceptional opportunity for both physicians and trainees to enhance their expertise and stay at the forefront of this rapidly evolving field.
Live Case Presentation by Prof. Cortese
Under the leadership of Prof. Bernardo Cortese, President of DCB Academy, a groundbreaking live case presentation was delivered at the DEBS Congress 2025. Prof. Cortese’s expert insights demonstrated the latest advancements in cardiovascular care, offering valuable, real-time guidance on complex clinical decision-making. This session provided attendees with hands-on experience and deepened the understanding of innovative techniques in cardiovascular medicine.
Trial Presentation at DEBS Congress 2025
At the DEBS Congress 2025, the largest congress in Europe dedicated to Drug-Coated Balloons (DCBs), DCB Academy and Fondazione RICpresented their latest clinical trial findings. This presentation highlighted groundbreaking research and innovative approaches in DCB technology, further advancing the field of cardiovascular interventions. The session sparked insightful discussions and reinforced the commitment to improving patient outcomes through cutting-edge treatments and collaboration in the cardiovascular community.
Leading the Charge with Drug-Coated Balloon Technology
DCB Academy proudly participated in the DEBS Congress 2025, Europe’s largest event dedicated to DCB technology. Among the many outstanding contributions, our fellow Dr. Filippo Luca Gurgoglione presented a compelling case on the use of Drug-Coated Balloons in complex lesions. The session was expertly moderated by Dr. Wojciech Wanha from DCB Academy, who guided the discussion with valuable insights and expertise. Dr. Gurgoglione’s presentation emphasized the transformative impact of DCB technology in improving procedural outcomes, particularly for high-risk patients.
Leading the Discussion on Advanced Lesion Preparation
DCB Academy proudly participated in the DEBS Congress 2025, the largest congress in Europe dedicated to DCB technology. Among the many key contributions, our fellow, Dr Leontin Lazar presented a highly impactful case on “Drug-Coated Balloons in CHIP Patients Lesion Preparation: Do It and Do It Hard!. Dr. Lazar‘s presentation underscored the critical importance of thorough lesion preparation in CHIP patients, highlighting the transformative potential of drug-coated balloons in improving procedural outcomes. His expertise reinforced how proper lesion preparation can optimize results for these high-risk patient populations.
Live Case Presentation by Prof. Cortese
Under the leadership of Prof. Bernardo Cortese, President of DCB Academy, a groundbreaking live case presentation was delivered at the DEBS Congress 2025. Prof. Cortese’s expert insights demonstrated the latest advancements in cardiovascular care, offering valuable, real-time guidance on complex clinical decision-making. This session provided attendees with hands-on experience and deepened the understanding of innovative techniques in cardiovascular medicine.
Trial Presentation at DEBS Congress 2025
At the DEBS Congress 2025, the largest congress in Europe dedicated to Drug-Coated Balloons (DCBs), DCB Academy and Fondazione RICpresented their latest clinical trial findings. This presentation highlighted groundbreaking research and innovative approaches in DCB technology, further advancing the field of cardiovascular interventions. The session sparked insightful discussions and reinforced the commitment to improving patient outcomes through cutting-edge treatments and collaboration in the cardiovascular community.
Leading the Charge with Drug-Coated Balloon Technology
DCB Academy proudly participated in the DEBS Congress 2025, Europe’s largest event dedicated to DCB technology. Among the many outstanding contributions, our fellow Dr. Filippo Luca Gurgoglione presented a compelling case on the use of Drug-Coated Balloons in complex lesions. The session was expertly moderated by Dr. Wojciech Wanha from DCB Academy, who guided the discussion with valuable insights and expertise. Dr. Gurgoglione’s presentation emphasized the transformative impact of DCB technology in improving procedural outcomes, particularly for high-risk patients.
Leading the Discussion on Advanced Lesion Preparation
DCB Academy proudly participated in the DEBS Congress 2025, the largest congress in Europe dedicated to DCB technology. Among the many key contributions, our fellow, Dr Leontin Lazar presented a highly impactful case on “Drug-Coated Balloons in CHIP Patients Lesion Preparation: Do It and Do It Hard!. Dr. Lazar‘s presentation underscored the critical importance of thorough lesion preparation in CHIP patients, highlighting the transformative potential of drug-coated balloons in improving procedural outcomes. His expertise reinforced how proper lesion preparation can optimize results for these high-risk patient populations.
DEB School XVIII in Ravenna